Skip to main content
Screener/Healthcare/Biotechnology

TARS — Tarsus Pharmaceuticals, Inc.

NASDAQ
$58.91-0.53 (-0.88%)
Mid CapHealthcareFastest GrowingLow Beta
$38.51
$85.25
$57.32
$59.09
EPS (TTM)$-1.14
P/E Ratio-40.00
Dividend Yield—
Market Cap$2.52B
Volume345K
Prev Close$59.54
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$162.1M-$7.0M$-0.1694.2%-4.3%
Q4 '25$151.7M-$8.4M$-0.2092.8%-5.5%
Q3 '25$118.7M-$12.6M$-0.3079.3%-10.6%
Q2 '25$102.7M-$20.3M$-0.4893.9%-19.8%
Q1 '25$78.3M-$25.1M$-0.6493.3%-32.1%
Q4 '24$66.4M-$23.1M$-0.6092.6%-34.8%
Q3 '24$48.1M-$23.4M$-0.6193.3%-48.7%
Q2 '24$40.8M-$33.3M$-0.8892.6%-81.6%
Get Your Daily Market Recap